Variant report
Variant | esv2553148 |
---|---|
Chromosome Location | chr9:22596878-22598201 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556713968 | chr9:22596886-22596887 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs368442832 | chr9:22596913-22596914 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576636003 | chr9:22596923-22596924 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs538759447 | chr9:22596925-22596926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545501241 | chr9:22596935-22596936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547511002 | chr9:22596938-22596939 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs5017640 | chr9:22596977-22596978 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs540526655 | chr9:22597017-22597018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187222364 | chr9:22597079-22597080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529070288 | chr9:22597120-22597121 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567308185 | chr9:22597212-22597213 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536212429 | chr9:22597252-22597253 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192109887 | chr9:22597313-22597314 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113786027 | chr9:22597318-22597319 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551183855 | chr9:22597330-22597331 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554307085 | chr9:22597333-22597334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10115145 | chr9:22597351-22597352 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs556162755 | chr9:22597384-22597385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs200701849 | chr9:22597433-22597434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs527251243 | chr9:22597435-22597436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs71888842 | chr9:22597437-22597438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs548085660 | chr9:22597470-22597471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536878706 | chr9:22597474-22597475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567928607 | chr9:22597498-22597499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs10115194 | chr9:22597508-22597509 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs112232620 | chr9:22597577-22597578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536921897 | chr9:22597663-22597664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375362361 | chr9:22597669-22597670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556828500 | chr9:22597684-22597685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570255861 | chr9:22597699-22597700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs577154913 | chr9:22597729-22597730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs539171968 | chr9:22597734-22597735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575451108 | chr9:22597755-22597756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs57168082 | chr9:22597800-22597801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs10124247 | chr9:22597823-22597824 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs10124298 | chr9:22597831-22597832 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs553673375 | chr9:22597870-22597871 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191625726 | chr9:22597959-22597960 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs138894406 | chr9:22598139-22598140 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs543374742 | chr9:22598140-22598141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs75811710 | chr9:22598158-22598159 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs79413356 | chr9:22598159-22598160 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575784534 | chr9:22598191-22598192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Glioblastoma multiforme | 21569311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Lung cancer | 21911935 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
head and neck squamous cell carcinoma | 21798897 | CNVD |
Cancer | 21253487 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Leukemia | 19602459 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Glioma | 20126413 | CNVD |
Melanoma | 17363583 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Cancer | 20581869 | CNVD |
Oral cancer | 22144094 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Breast cancer | 17142309 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:22593400-22599000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
2 | chr9:22595800-22597000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr9:22596000-22618000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr9:22596200-22597400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr9:22596400-22601200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr9:22597400-22597800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr9:22597800-22600000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |